Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.42
-
NAV
₹14.47
-
Fund Started
27 Jun 2023
-
Fund Size
₹350.44 Cr
-
Exit Load
Exit load of 1%, if redeemed within 15 days.
-
1 Year
7.34%
-
3 Year
-
-
5 Year
-
-
Equity
99.38%
-
Cash
-16.23%
-
Top 10 Holdings
SMS Pharmaceuticals Ltd. | 9.98% |
Anthem Biosciences Ltd. | 9.25% |
Viyash Scientific Limited | 9.05% |
Aster DM Healthcare Ltd. | 8.34% |
Zydus Wellness Ltd. | 7.05% |
Pfizer Ltd. | 6.93% |
Alivus Life Sciences Ltd | 6.41% |
ICICI Prudential Life Insurance Company Ltd. | 5.56% |
Aurobindo Pharma Ltd. | 5.36% |
Biocon Ltd. | 4.89% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
-
Launch Date
27 Jun 2023
-
